The Genomics Market is receiving increased attention from pharmaceutical and biotechnology companies. Genomic information can support drug discovery by helping researchers identify disease-related genes, molecular targets, and biomarkers. It can also assist in designing targeted clinical trials and companion diagnostic strategies.

Pharmaceutical and biotechnology companies are projected to represent a rapidly expanding end-user segment, with a forecast CAGR of 11.7% through 2035. The growing use of genomics in precision therapeutics and biomarker-driven drug development is creating new commercial opportunities. Market Forecast expectations remain positive as pharmaceutical R&D increasingly incorporates genomic information.

FAQ: How does genomics support drug discovery?
It helps researchers identify genetic targets, biomarkers, and disease mechanisms that can guide therapeutic development.

FAQ: Who uses genomic technologies?
Pharmaceutical companies, biotechnology firms, hospitals, diagnostic laboratories, and research institutions are major users.